| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 100.00% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 103.25 | -0.16 (-0.15%) | 82.00 - 104.63 | 1.6 thousand |
Market data as of 9:40AM 06/19/13. Quotes are delayed by at least 15 min.
The investment seeks to replicate the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. Components primarily include health care and pharmaceuticals companies. The fund is non-diversified.
| Open | 103.60 |
|---|---|
| Previous Close | 103.41 |
| Day's Range | 103.25 - 103.61 |
| Avg Volume (10 Day) | 34.8K |
| Total Assets | $458.59M |
| Expense Ratio | 0.47% |
| Yield (Trailing 12 Mo.) | 1.66% |
| Fund Inception | 05/01/2006 |
| Timeframe | IHE | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 1.70% | 2.34% | 2.69% |
| 3 Month | 9.57% | 8.22% | 11.87% |
| Year-to-Date | 18.87% | 15.37% | 21.07% |
| 1 Year | 26.60% | 27.28% | 35.83% |
| 3 Year | 24.11% | 16.87% | 21.93% |
| 5 Year | 16.60% | 5.43% | 13.47% |
| 10 Year | -- | 7.58% | 8.36% |
| Since Inception | 12.02% | 10.42% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 100.00% |
| Utilities | 0.00% | |
|---|---|---|
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 0.00% |
| Valuation | IHE | Category Range |
|---|---|---|
| Price/Earnings | 20.15 | |
| Price/Book | 3.51 | |
| Price/Sales | 3.11 | |
| Price/Cash Flow | 13.39 | |
| Dividend Yield | 1.72 | |
| LT Earnings | 10.83 | |
| Historical Earnings | 2.27 | |
| Sales Growth | 6.58 | |
| Cash-Flow Growth | 2.28 | |
| Book-Value Growth | 7.31 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() ![]() | |
| Risk | Below Avg | |
| Return | Above Avg |
| Beta | 0.56 |
|---|---|
| Standard Deviation | 12.14 |
| Alpha | 14.73 |
| Sharpe Ratio | 1.85 |
| Mean | 25.05 |
| R-Squared | 51.59 |
| Pretax Return | 24.11% |
|---|---|
| Tax-adjusted Return | 23.74% |
| Tax Cost Ratio | 0.30% |
| Potential Cap Gains | 23.95% |